Results
1 -
10 of
26Aktuelle Arzneimitteltherapie der Hepatitis??C, Der Internist Chronische Hepatitis??C, Der Internist Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis, Journal of Gastroenterology Treatment of hepatitis C in special populations, Journal of Gastroenterology Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection, Journal of Gastroenterology Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection, Journal of Gastroenterology Neue Zweierkombi gegen Hepatitis C, CME Diagnosis and Management of Hepatitis C Infection in Primary Care Settings, Journal of General Internal Medicine Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease, Digestive Diseases and Sciences Treatment of DAA-Experienced Patients with Chronic Hepatitis C, Current Hepatology Reports